Cargando…

Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men

Background: Asprosin (ASP) is a recently discovered adipocyte factor that participates in glucose metabolism and inflammatory reactions. Recent findings suggest that it may be involved in the regulation of sex hormone secretion in the hypothalamic-pituitary-gonad (HPG) axis, but no studies have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Tingting, Song, Chenglin, Yu, Yajie, Cheng, Yang, Lu, Hongyan, Li, Jing, Yang, Yang, Tang, Donghui, Yi, Xuejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549162/
https://www.ncbi.nlm.nih.gov/pubmed/36225310
http://dx.doi.org/10.3389/fphys.2022.896735
_version_ 1784805606742294528
author Yao, Tingting
Song, Chenglin
Yu, Yajie
Cheng, Yang
Lu, Hongyan
Li, Jing
Yang, Yang
Tang, Donghui
Yi, Xuejie
author_facet Yao, Tingting
Song, Chenglin
Yu, Yajie
Cheng, Yang
Lu, Hongyan
Li, Jing
Yang, Yang
Tang, Donghui
Yi, Xuejie
author_sort Yao, Tingting
collection PubMed
description Background: Asprosin (ASP) is a recently discovered adipocyte factor that participates in glucose metabolism and inflammatory reactions. Recent findings suggest that it may be involved in the regulation of sex hormone secretion in the hypothalamic-pituitary-gonad (HPG) axis, but no studies have been reported in related populations. The purpose of this study was to evaluate the changes in serum ASP levels in healthy men and obese men, as well as before and after exercise weight loss, and to investigate male hypogonadism, insulin resistance, inflammatory response, and relationships induced by ASP and obesity. Methods: Thirty-eight young male volunteers were recruited and divided into a normal group (n = 20) and an obese group (n = 18) according to their body mass index. Fourteen of the obese men underwent a 14-week exercise and diet intervention (first 8 weeks of aerobic exercise at 60%–70% HR(max) for 30–50 min/4 days a week). Beginning at week 9, the intensity was increased to 75% HR(max). Participants in the obese groups maintained a calorie-restricted diet throughout the study period. Results: Serum ASP levels in the obese group were significantly higher than those in the normal group, and serum gonadotropin-releasing hormone (GnRh), luteinizing hormone (LH), and testosterone (T) levels were decreased. After 14 weeks of exercise and diet intervention, serum ASP decreased significantly, the levels of body weight, lean body weight, body fat rate, fasting insulin (FINS), homeostatic model assessment for insulin resistance, TNF-α, IL-6, and IL-1β decreased significantly, and the serum GnRH, LH, and T levels increased significantly. ASP was positively correlated with body weight, body fat percentage, FINS, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β and negatively correlated with relative lean body weight and serum LH and T levels. Conclusion: The serum ASP levels were increased in obese men compared with those of normal weight individuals, resulting in a chronic inflammatory reaction, high serum insulin, and HPG axis injury. Fourteen weeks of exercise and diet intervention effectively alleviated this phenomenon. It has been speculated that ASP might regulate male reproductive function by regulating the inflammatory response and insulin sensitivity.
format Online
Article
Text
id pubmed-9549162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95491622022-10-11 Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men Yao, Tingting Song, Chenglin Yu, Yajie Cheng, Yang Lu, Hongyan Li, Jing Yang, Yang Tang, Donghui Yi, Xuejie Front Physiol Physiology Background: Asprosin (ASP) is a recently discovered adipocyte factor that participates in glucose metabolism and inflammatory reactions. Recent findings suggest that it may be involved in the regulation of sex hormone secretion in the hypothalamic-pituitary-gonad (HPG) axis, but no studies have been reported in related populations. The purpose of this study was to evaluate the changes in serum ASP levels in healthy men and obese men, as well as before and after exercise weight loss, and to investigate male hypogonadism, insulin resistance, inflammatory response, and relationships induced by ASP and obesity. Methods: Thirty-eight young male volunteers were recruited and divided into a normal group (n = 20) and an obese group (n = 18) according to their body mass index. Fourteen of the obese men underwent a 14-week exercise and diet intervention (first 8 weeks of aerobic exercise at 60%–70% HR(max) for 30–50 min/4 days a week). Beginning at week 9, the intensity was increased to 75% HR(max). Participants in the obese groups maintained a calorie-restricted diet throughout the study period. Results: Serum ASP levels in the obese group were significantly higher than those in the normal group, and serum gonadotropin-releasing hormone (GnRh), luteinizing hormone (LH), and testosterone (T) levels were decreased. After 14 weeks of exercise and diet intervention, serum ASP decreased significantly, the levels of body weight, lean body weight, body fat rate, fasting insulin (FINS), homeostatic model assessment for insulin resistance, TNF-α, IL-6, and IL-1β decreased significantly, and the serum GnRH, LH, and T levels increased significantly. ASP was positively correlated with body weight, body fat percentage, FINS, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β and negatively correlated with relative lean body weight and serum LH and T levels. Conclusion: The serum ASP levels were increased in obese men compared with those of normal weight individuals, resulting in a chronic inflammatory reaction, high serum insulin, and HPG axis injury. Fourteen weeks of exercise and diet intervention effectively alleviated this phenomenon. It has been speculated that ASP might regulate male reproductive function by regulating the inflammatory response and insulin sensitivity. Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9549162/ /pubmed/36225310 http://dx.doi.org/10.3389/fphys.2022.896735 Text en Copyright © 2022 Yao, Song, Yu, Cheng, Lu, Li, Yang, Tang and Yi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Yao, Tingting
Song, Chenglin
Yu, Yajie
Cheng, Yang
Lu, Hongyan
Li, Jing
Yang, Yang
Tang, Donghui
Yi, Xuejie
Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title_full Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title_fullStr Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title_full_unstemmed Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title_short Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
title_sort diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549162/
https://www.ncbi.nlm.nih.gov/pubmed/36225310
http://dx.doi.org/10.3389/fphys.2022.896735
work_keys_str_mv AT yaotingting dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT songchenglin dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT yuyajie dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT chengyang dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT luhongyan dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT lijing dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT yangyang dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT tangdonghui dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen
AT yixuejie dietandexerciseinterventionsreduceserumasprosinandthecorrespondinghypothalamicpituitarygonadaxisdysfunctioninobesemen